Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Parkinson's Disease

Free Subscription 16.09.2019 2 Brain Res 1 Exp Neurol 2 Int J Neurosci 2 J Neural Transm (Vienna) 1 J Neurochem 3 Lancet Neurol 3 Mov Disord 1 Neurobiol Dis 2 Neurol Genet 2 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Brain Res

1. CAVELLI M, Prunell G, Costa G, Velasquez N, et al
   Electrocortical high frequency activity and respiratory entrainment in 6-hydroxydopamine model of Parkinson's disease.
   Brain Res. 2019 Sep 6:146439. doi: 10.1016/j.brainres.2019.146439.
   PubMed     Text format     Abstract available
   
   
2. NADEAU J, Smith T, Lamontagne-Proulx J, Bourque M, et al
   Neuroprotection and immunomodulation in the gut of parkinsonian mice with a plasmalogen precursor.
   Brain Res. 2019 Sep 13:146460. doi: 10.1016/j.brainres.2019.146460.
   PubMed     Text format     Abstract available
   
   

   
   Exp Neurol

3. ZHANG J, Lv S, Tang G, Bian G, et al
   Activation of calcium-impermeable GluR2-containing AMPA receptors in the lateral habenula produces antidepressant-like effects in a rodent model of Parkinson's disease.
   Exp Neurol. 2019;322:113058.
   PubMed     Text format     Abstract available
   
   

   
   Int J Neurosci

4. KATAOKA H, Sugie K
   Risk for later Rapid Eye Movement sleep behavior disorder in Parkinson's disease: A 6-year prospective study.
   Int J Neurosci. 2019 Sep 13:1-11. doi: 10.1080/00207454.2019.1667796.
   PubMed     Text format     Abstract available
   
   
5. YANG Y, Qian J, Mei J, Zhong K, et al
   In vivo detection of metabolic changes in the striatum of proteasomal inhibition-induced Parkinson's disease in rats using proton MR spectroscopy at 9.4 T.
   Int J Neurosci. 2019 Sep 13:1-12. doi: 10.1080/00207454.2019.1667783.
   PubMed     Text format     Abstract available
   
   

   
   J Neural Transm (Vienna)

6. ROOS DS, Twisk JWR, Raijmakers PGHM, Doty RL, et al
   Hyposmia as a marker of (non-)motor disease severity in Parkinson's disease.
   J Neural Transm (Vienna). 2019 Sep 12. pii: 10.1007/s00702-019-02074.
   PubMed     Text format     Abstract available
   
   
7. MOSSNER JM, Patil PG, Chou KL
   Subthalamic nucleus deep brain stimulation improves dyskinesias in Parkinson's disease beyond levodopa reduction.
   J Neural Transm (Vienna). 2019 Sep 7. pii: 10.1007/s00702-019-02076.
   PubMed     Text format     Abstract available
   
   

   
   J Neurochem

8. LI T, Zhang W, Kang X, Yang R, et al
   Salidroside Protects Dopaminergic Neurons by Regulating the Mitochondrial MEF2D-ND6 Pathway in the MPTP/MPP(+) -Induced Model of Parkinson's Disease.
   J Neurochem. 2019 Sep 14. doi: 10.1111/jnc.14868.
   PubMed     Text format     Abstract available
   
   

   
   Lancet Neurol

9. BLAUWENDRAAT C, Nalls MA, Singleton AB
   The genetic architecture of Parkinson's disease.
   Lancet Neurol. 2019 Sep 11. pii: S1474-4422(19)30287.
   PubMed     Text format     Abstract available
   
   
10. VAN DER KOLK NM, de Vries NM, Kessels RPC, Joosten H, et al
    Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial.
    Lancet Neurol. 2019 Sep 11. pii: S1474-4422(19)30285.
    PubMed     Text format     Abstract available
    
    
11. ELLIS T
    Exercise in Parkinson's disease: are we narrowing in on the essential elements?
    Lancet Neurol. 2019 Sep 11. pii: S1474-4422(19)30348.
    PubMed     Text format    
    
    

    
    Mov Disord

12. SU TH, Yang HC, Tseng TC, Chou SW, et al
    Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism.
    Mov Disord. 2019 Sep 10. doi: 10.1002/mds.27848.
    PubMed     Text format     Abstract available
    
    
13. IWAKI H, Blauwendraat C, Leonard HL, Kim JJ, et al
    Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts.
    Mov Disord. 2019 Sep 10. doi: 10.1002/mds.27845.
    PubMed     Text format     Abstract available
    
    
14. LEE PC, Artaud F, Cormier-Dequaire F, Rascol O, et al
    Examining the Reserve Hypothesis in Parkinson's Disease: A Longitudinal Study.
    Mov Disord. 2019 Sep 13. doi: 10.1002/mds.27854.
    PubMed     Text format     Abstract available
    
    

    
    Neurobiol Dis

15. CHEN CC, Yeh CH, Chan HL, Chang YJ, et al
    Subthalamic nucleus oscillations correlate with vulnerability to freezing of gait in patients with Parkinson's disease.
    Neurobiol Dis. 2019 Sep 5:104605. doi: 10.1016/j.nbd.2019.104605.
    PubMed     Text format     Abstract available
    
    

    
    Neurol Genet

16. 
    Erratum: Genome-wide Brain DNA methylation analysis suggests epigenetic reprogramming in Parkinson disease.
    Neurol Genet. 2019;5:e355.
    PubMed     Text format     Abstract available
    
    
17. 
    Erratum: Genetic risk of Parkinson disease and progression: An analysis of 13 longitudinal cohorts.
    Neurol Genet. 2019;5:e354.
    PubMed     Text format     Abstract available
    
    

    
    Rev Neurol (Paris)

18. TORUN NA, Senel GB, Gunduz A, Karadeniz D, et al
    Sleep parameters associated with long-term outcome following subthalamic deep brain stimulation in Parkinson's disease.
    Rev Neurol (Paris). 2019 Sep 11. pii: S0035-3787(19)30473.
    PubMed     Text format     Abstract available
    
    
19. CAPARROS LEFEBVRE D
    Food toxins and the Caribbean Parkinson plus types.
    Rev Neurol (Paris). 2019 Sep 10. pii: S0035-3787(19)30616.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: